NCT04692922

Brief Summary

By collecting multimodal metrics (e.g., clinical factors, neuroimaging, and EEG) in the early phase of severe brain injury (i.e., during the acute hospitalization when a patient has impaired consciousness), and measuring the patients' recovery of consciousness, function, and quality of life in the late phase (at 6 months following the brain injury), we aim to construct an algorithm that synthesizes the results of these metrics to help predict recovery.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
73mo left

Started Jul 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
5.5 years until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2031

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2032

Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

5 years

First QC Date

November 10, 2020

Last Update Submit

April 21, 2026

Conditions

Keywords

Disorders of consciousnessAdvanced neuroimagingNeuroprognostication

Outcome Measures

Primary Outcomes (1)

  • Glasgow Outcome Scale-Extended

    Metric of neurologic function. The minimum score is 1, and the maximum score is 8. Higher scores represent less disability (8 represents non-disabling symptoms, 1 represents death).

    6 months following enrollment

Study Arms (1)

Patients with disorders of consciousness

patients with a diagnosis of coma, vegetative state, or minimally conscious state minus (i.e. minimally conscious state without language function)

Diagnostic Test: MRIDiagnostic Test: EEG

Interventions

MRIDIAGNOSTIC_TEST

MRI will include structural sequences (e.g., T1 weighted imaging, T2 weighted imaging, T2 FLAIR, diffusion weighted imaging with apparent diffusion coefficient, susceptibility weighted imaging, and diffusion tensor imaging). Using the structural sequences we will make note of the types of brain lesions (e.g., ischemic stroke, hemorrhage, hypoxic-ischemic brain injury), and the locations of these brain lesions. MRI will also include fMRI under three conditions: while the patient is at rest (to evaluate resting state functional connectivity), while the patient is exposed to auditory stimuli (to evaluate passive fMRI responses to stimuli), and while the patient is asked to follow commands (to evaluate active fMRI responses to tasks).

Patients with disorders of consciousness
EEGDIAGNOSTIC_TEST

The EEG will include resting, stimulus-based, and task-based assessments of brain function.

Patients with disorders of consciousness

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Disorders of consciousness following acute brain injury

You may qualify if:

  • Acute brain injury (including ischemic stroke, intracranial hemorrhage, anoxic brain injury, traumatic brain injury, encephalitis)
  • Inability to follow commands, speak intelligibly, or communicate (i.e., diagnosis of coma, vegetative state, or minimally conscious state minus) due to the underlying brain injury and within 28 days of the brain injury
  • Age 18 or greater.

You may not qualify if:

  • Subjects will be excluded if they do not speak English (given the reliance on verbal questionnaires conducted in English) or if they regain the ability to follow commands, speak intelligibly or communicate (i.e., improves to minimally conscious state plus or greater) before they undergo MRI or EEG.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Consciousness Disorders

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Brian L Edlow, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yelena Bodien, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 10, 2020

First Posted

January 5, 2021

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

June 30, 2031

Study Completion (Estimated)

June 30, 2032

Last Updated

April 24, 2026

Record last verified: 2026-04